Home › B-Cell Lymphoma › Pennsylvania › Philadelphia

Pag-aaral pangklinika para sa B-Cell Lymphoma sa Philadelphia, PA

Isang pag-aaral para sa B-Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Philadelphia. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

Nagre-recruitPhase 1

Children's Hospital of Philadelphia, Philadelphia

Edad 0 hanggang 18 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06173518

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Nagre-recruitObservasyonal na pag-aaral

Children's Hospital of Philadelphia, Philadelphia

Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06131801

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1

University of Pennsylvania Abramson Cancer Center, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Nagre-recruitPhase 2

Research Site, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06526793

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

Nagre-recruitPhase 1/2

Fox Chase Cancer Center, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06634589

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Nagre-recruitPhase 1/2

Research Site, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06564038

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Nagre-recruitPhase 1/2

Thomas Jefferson University, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Nagre-recruitPhase 1/2

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT04104776

CD45BE-HSPC + CART-45 Cells

Nagre-recruitPhase 1

University of Pennsylvania, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07451054

SynKIR-310 for Relapsed/Refractory B-NHL

Nagre-recruitPhase 1

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 14, 2026 · NCT06544265

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Nagre-recruitPhase 1

Children's Hospital of Philadelphia, Philadelphia

Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Dis 6, 2024 · NCT05476770

Pag-aaral para sa B-Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Philadelphia

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.